The encapsulation and release of guanosine from PEGylated liposomes

Journal of Liposome Research

Volumn 19, Issue 1, 2009, Pages 29-36

  Er, Yan ^a   Barnes, Timothy J ^a   Fornasiero, Daniel ^a   Prestidge, Clive A ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Drug release kinetics; Guanosine; Liposomes; Polyethylene glycol (PEG)

Indexed keywords

GUANOSINE; LIPID; LIPOSOME; MACROGOL; MACROGOL DERIVATIVE;

ACIDITY; ARTICLE; CONTROLLED STUDY; DRUG RELEASE; ENCAPSULATION; ENERGY; KINETICS; LIPID BILAYER; MOLECULAR WEIGHT; PRIORITY JOURNAL; TEMPERATURE; CHEMISTRY; HEAT;

GUANOSINE; HOT TEMPERATURE; KINETICS; LIPID BILAYERS; LIPOSOMES; POLYETHYLENE GLYCOLS;

EID: 70349577793     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100802673940     Document Type: Article

References (39)

1. Al-Angary AA, Al-Meshal MA, et al. (1996). Evaluation of liposomal formulations containing the antimalarial agent arteether. Int J Pharm 128:163-168.
2. Barnes TJ, Prestidge CA. (2000). PEO-PPO-PEO block copolymers at the emulsion droplet-water interface. Langmuir 16:4116-4121.
3. Brandt WW. (1959). Model calculation of the temperature dependence of small molecule diffusion in high polymers. 63:1080-11058
4. Capek I. (2002). Sterically and electrosterically stabilized emulsion polymerization: kinetics and preparation. Adv Colloid Interface Sci 99:77-162.
5. Èeh B, Winterhalter M, et al. (1997). Stealth liposomes: from theory to product. Adv Drug Delivery Rev 24:165-177.
6. Chen HM, Langer R, Edwards DA. (1997). A film tension theory of phagocytosis. J Coll Interface Sci 190:118-133.
7. Chi SC, Jun HW. (1991). Release rates of ketoprofen from poloxamer gels in a membraneless diffusion cell. J Pharm Sci 80:280-283.
8. Choi JH, Choi WY, et al. (2005). Diffusivity of potassium sorbate in β-carrageenan based antimicrobial film. LWT Food Sci Technol 38:417-423.
9. Crommelin DJA, Schreier H. (1994). Liposomes. Colloidal drug delivery systems. In: Kreuter J (ed), Drugs and the Pharmaceutical Sciences, Vol.66(pp 73-190) Marcel Dekker Inc., New York.
10. Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. European J Pharm Sci 13:123-133.
11. Dhoot ON, Wheatley AM. (2003). Microencapsulated liposomes in controlled drug delivery: strategies to modulate drug release and eliminate the burst effect. J Pharm Sci 92:679-689.
12. Emara LH. (1994). Thermodynamic of niclosamide diffusion from elastomeric matrices. Egyptian J Pharm Sci 35:663-673.
13. Er Y, Prestidge CA, Fornasiero D. (2004). Attenuated total reflectance infrared studies of liposome adsorption at the solid-liquid interface. Colloid Surf B: Biointerf 36:147-153.
14. García-Fuentes M, Torres D, Alonso M.J. (2002). Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Coll. Surf. B: Biointerf 27:159-168.
15. Goracinova K, Mladenovska K, et al. (2002). Release profile of lidocaine HCl from topical liposomal gel formulation. Int J Pharm 242:381-384.
16. Goldberg AH, Higuchi WI, Ho NF, Zographi G. (1967). Mechanisms of interphase transport. I. Theoretical considerations of diffusion and interfacial barriers in transport of solubilized systems. J Pharm Sci 56:1432-1437.
17. Higuchi T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 50:874-875.
18. Karasulu E, Karasulu HY, et al. (2003). Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates. Eur J Pharm Sci 19:99-104.
19. Koning GA, Morselt HW, et al. (1999). Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells. Biochim Biophys Acta Biomembr 1420:153-167.
20. Langer R, Peppas NA. (2003). Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J 49:2990-3006.
21. Leo E, Cameroni R, Forni F. (1999). Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticles conjugates. J Pharmaceutics 180:23-30.
22. Li XG, Zhai SD. (2003). Study of the in vitro and in vivo pharmaceutical behaviour of monoammonium glycyrrhizinate liposomes. Chin J New Drugs 12:915-918.
23. Margalit R, Alon R, et al. (1991). Liposomal drug delivery: thermodynamic and chemical kinetic considerations. J Contr Rel 17:285-296.
24. Merck Index. (1998). Merck & Co. Inc., West Point.
25. Miles HT, Howard FB, Frazier J. (1963). Tantomerism and protoration of guanosine. Science 142:1458-1463.
26. Moghimi SM, Szebeni J. (2003). Stealth liposomes and long-circulating nanoparticles: critical issues in pharmacokinetics, opsonization, and protein-binding properties. Prog Lipid Res 42:463-478.
27. Muranushi N, Nakajima Y, et al. (1980). Mechanism for the inducement of the intestinal absorption of poorly absorbed drugs by mixed micelles. II. Effect of the incorporation of various lipids on the permeability of liposomal membranes. Int J Pharm 4:281-290. (Pubitemid 10065795)
28. Narasimhan B, Mallapragada SK, Peppas NA. (1999). Release kinetics, data interpretation. Volume 2. In: Mathiowitz E (ed.), Encyclopaedia of Controlled Drug Delivery New York:Wiley.
29. Prestidge CA, Barnes TJ, Simovic S. (2004). Polymer and particle adsorption at the PDMS-droplet-water interface. Adv Coll Interface Sci 108-109:105-118.
30. Rege PR, Vilivalam VD, Collins CC, (1998). Development in release testing of topical dosage forms: use of the Enhancer Cell™ with automated sampling. J Pharm Biomed Anal 17:1225-1233.
31. Silvander M, Hansson P, Edwards K. (2000). Liposomal surface potential and bilayer packing as affected by PEG-lipid inclusion. Langmuir 16:3696-3702.
32. Simovic S, Prestidge CA. (2003). Adsorption of hydrophobic silica nanoparticles at the PDMS droplet-water interface. Langmuir 19:8364-8370.
33. Takagi I, Shimizu H, Yotsuyanagi T. (1996). Application of alginate gel as a vehicle for liposomes. Part 1. Factors affecting the loading of drug-containing liposomes and drug release. Chem Pharma Bull 44:1941-1947.
34. Torchilin VP, Papisov MI. (1994). Why do polyethylene glycol-coated liposomes circulate so long? J Liposome Res 4:725-739.
35. Vemuri S, Rhodes CT. (1995). Development and validation of a drug release rate method for a water soluble drug in a liposome preparation. Drug Dev Ind Pharm 21:1353-1364.
36. Vinadé ER, Izquierdo I, et al. (2004). Oral administration of guanosine impairs inhibitory avoidance performance in rats and mice. Neurobiol Learn Mem 81:137-143.
37. Webb MS, Saxon D, et al. (1998). Comparison of different hydrophobic anchors conjugated to poly (ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochim Biophys Acta 1372:272-282.
38. Woodle MC. (1995). Sterically stabilized liposome therapeutics. Adv Drug Delivery Rev 16:249-265.
39. Working PK, Newman MS, Sullivan T, Yarrington J. (1999). Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. J Pharmacol Exp Ther 289:1128-1133.